Clinical Trial Update: Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/3 trial evaluating exenatide for impaired hypoglycaemic awareness in type 1 diabetes. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Diabetes Mellitus, Type 1, Hypoglycemia | Phase 2, Phase 3 | Status: COMPLETED